-
Recent Posts
- Avid Bioservices Announces Addition of Novel Bacteriophage Production System at Upcoming BIO Convention as Part of a Collaboration with Phage Pharmaceuticals
- California FDB Grants Drug Manufacturing License to Phage Pharmaceuticals
- Phage Pharmaceuticals to File Investigational New Drug (IND) Application Using Its Lead Drug Candidate, FGF-1, for a First-in-Class Indication to Repair Tympanic Membrane Perforations
- Phage Pharmaceuticals and Stamford Bioprocess Technologies Sign Letter of Intent
- Phage Pharmaceuticals Executes a Letter of Intent with Viva Biotech
Archives
Categories
Monthly Archives: November 2010
Phage Pharmaceuticals Receives Grant for Qualifying Therapeutic Discovery Project
SAN DIEGO, November 3, 2010 — Phage Pharmaceuticals, Inc., a private San Diego-based clinical-stage specialty biopharmaceutical developer and manufacturer of therapeutic proteins, announced today that it has been awarded a grant of $244,479.25 under the Qualifying Therapeutic Discovery Project Program. … Continue reading
Posted in News
Leave a comment